Stay updated on KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Sign up to get notified when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.

Latest updates to the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page
- ChecktodayChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.4.2. The prior Revision: v3.4.1 notice and the government funding lapse notice have been removed.SummaryDifference0.5%

- Check43 days agoChange DetectedAdded a government funding lapse notice on the page informing users that information may not be up to date and actions may be delayed. Updated the system revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check50 days agoChange DetectedUI and metadata updates were made: a glossary toggle was added, QC-related date label capitalization was updated, No FEAR Act data capitalization was normalized, and the site revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page now displays revision v3.3.4, replacing the previous v3.3.3.SummaryDifference0.1%

Stay in the know with updates to KX2-361 Safety & PK in Refractory Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KX2-361 Safety & PK in Refractory Malignancies Clinical Trial page.